{"AllianceGenome": "17013", "HGNC": "17013", "MIM": "604463", "_id": "11126", "_version": 1, "accession": {"genomic": ["AC242845.1", "AL390725.16", "CH471244.1", "CP068277.2", "NC_000001.11", "NC_060925.1"], "protein": ["AAC72302.1", "AAH14465.1", "ABV89736.1", "ABV89737.1", "CAG46665.1", "CAG46686.1", "CAI13713.1", "CAI13714.1", "EAW71440.1", "NP_008984.1", "O95971.1", "XP_005272986.1", "XP_011507406.1", "XP_054189951.1", "XP_054189952.1"], "rna": ["AA463248.1", "AF060981.1", "AI241015.1", "AK128370.1", "BC014465.1", "CD638675.1", "CR541867.1", "CR541888.1", "EU016100.1", "EU016101.1", "NM_007053.4", "NR_103845.2", "XM_005272929.4", "XM_011509104.3", "XM_054333976.1", "XM_054333977.1"], "translation": [{"protein": "NP_008984.1", "rna": "NM_007053.4"}, {"protein": "XP_011507406.1", "rna": "XM_011509104.3"}, {"protein": "ABV89736.1", "rna": "EU016100.1"}, {"protein": "XP_005272986.1", "rna": "XM_005272929.4"}, {"protein": "CAG46665.1", "rna": "CR541867.1"}, {"protein": "AAC72302.1", "rna": "AF060981.1"}, {"protein": "CAG46686.1", "rna": "CR541888.1"}, {"protein": "ABV89737.1", "rna": "EU016101.1"}, {"protein": "AAH14465.1", "rna": "BC014465.1"}, {"protein": "XP_054189952.1", "rna": "XM_054333977.1"}, {"protein": "XP_054189951.1", "rna": "XM_054333976.1"}]}, "alias": ["BY55", "NK1", "NK28"], "ensembl": {"gene": "ENSG00000117281", "protein": ["ENSP00000235933", "ENSP00000358294", "ENSP00000385199", "ENSP00000462594", "ENSP00000483935"], "transcript": ["ENST00000235933", "ENST00000369288", "ENST00000401557", "ENST00000584442", "ENST00000616463"], "translation": [{"protein": "ENSP00000483935", "rna": "ENST00000616463"}, {"protein": "ENSP00000358294", "rna": "ENST00000369288"}, {"protein": "ENSP00000235933", "rna": "ENST00000235933"}, {"protein": "ENSP00000385199", "rna": "ENST00000401557"}, {"protein": "ENSP00000462594", "rna": "ENST00000584442"}], "type_of_gene": "protein_coding"}, "entrezgene": "11126", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.58522115, "exp_mis": 52.7636752, "exp_syn": 23.7575826, "lof_z": -0.160110968312026, "mis_z": 0.522777180103983, "mu_lof": 4.3325208581e-07, "mu_mis": 4.50894459416e-06, "mu_syn": 1.94887748618e-06, "n_lof": 7.0, "n_mis": 45.0, "n_syn": 25.0, "p_li": 1.90559903419166e-05, "p_null": 0.730579136234772, "p_rec": 0.269401807774886, "syn_z": -0.158021722067878}, "bp": 546, "cds_end": 145706758, "cds_start": 145696592, "n_exons": 4, "nonpsych": {"exp_lof": 5.8777183, "exp_mis": 47.6736766, "exp_syn": 21.4203598, "lof_z": -0.454620985057583, "mis_z": 0.487514703060282, "mu_lof": 4.3325208581e-07, "mu_mis": 4.50894459416e-06, "mu_syn": 1.94887748618e-06, "n_lof": 7.0, "n_mis": 41.0, "n_syn": 21.0, "p_li": 1.24868038624467e-05, "p_null": 0.799167167262313, "p_rec": 0.200820345933824, "syn_z": 0.057183600019356}, "nontcga": {"exp_lof": 6.05035793, "exp_mis": 48.534539, "exp_syn": 21.84892858, "lof_z": -0.380847045115777, "mis_z": 0.467303817580719, "mu_lof": 4.3325208581e-07, "mu_mis": 4.50894459416e-06, "mu_syn": 1.94887748618e-06, "n_lof": 7.0, "n_mis": 42.0, "n_syn": 24.0, "p_li": 1.37028765268185e-05, "p_null": 0.772813654842912, "p_rec": 0.227172642280562, "syn_z": -0.291381380780113}, "transcript": "ENST00000235933.6"}, "exons": [{"cdsend": 145738493, "cdsstart": 145728327, "chr": "1", "position": [[145719498, 145719559], [145724800, 145724906], [145728255, 145728400], [145730743, 145731070], [145735996, 145736134], [145738485, 145739288]], "strand": 1, "transcript": "NM_007053", "txend": 145739288, "txstart": 145719498}, {"cdsend": 145739288, "cdsstart": 145739288, "chr": "1", "position": [[145719498, 145719559], [145724800, 145724906], [145735996, 145736134], [145738485, 145739288]], "strand": 1, "transcript": "NR_103845", "txend": 145739288, "txstart": 145719498}], "exons_hg19": [{"cdsend": 145706758, "cdsstart": 145696592, "chr": "1", "position": [[145695797, 145696600], [145698952, 145699090], [145704016, 145704343], [145706685, 145706830], [145710178, 145710284], [145715525, 145715586]], "strand": -1, "transcript": "NM_007053", "txend": 145715586, "txstart": 145695797}, {"cdsend": 145715586, "cdsstart": 145715586, "chr": "1", "position": [[145695797, 145696600], [145698952, 145699090], [145710178, 145710284], [145715525, 145715586]], "strand": -1, "transcript": "NR_103845", "txend": 145715586, "txstart": 145695797}], "generif": [{"pubmed": 11978774, "text": "BY55 functions as a co-receptor in TCR signal transduction of a human cytotoxic effector T lymphocyte subset lacking CD28 expression"}, {"pubmed": 15073036, "text": "CD94-expressing cells with cytolytic activity against the recipient's leukemic and tumor cells without enhancement of alloresponse might be able to be expanded from donor G-PBMCs."}, {"pubmed": 15494480, "text": "The CD160 receptor represents a unique triggering surface molecule expressed by cytotoxic NK cells that participates in the inflammatory response and determines the type of subsequent specific immunity."}, {"pubmed": 17218942, "text": "We report that CD160 acts as a co-activator receptor for CD3-induced proliferation of CD4+ CD160+ T cells isolated from inflammatory skin lesions."}, {"pubmed": 17237375, "text": "short-time incubation of NK lymphocytes with IL-15 converts the membrane-bound CD160 to a soluble form; activated NK lymphocytes release a soluble form of CD160 that functionally impairs the MHC-I-specific cytotoxic CD8(+) T lymphocyte responsiveness"}, {"pubmed": 18193050, "text": "CD160 serves as a negative regulator of CD4+ T cell activation through its interaction with HVEM."}, {"pubmed": 19109136, "text": "Apart from CD160 mRNA, three additional transcripts generated through alternative splicings of the CD160 gene can be detected in peripheral blood natural killer (NK) cells but not in peripheral blood CD8-positive T cells, upon activation."}, {"pubmed": 19626042, "text": "Site-directed mutagenesis showed that the predicted AML-1 site is essential for the regulation of CD160 gene expression."}, {"pubmed": 20164468, "text": "Activation through CD160 leads to PI3K-dependent chronic lymphocytic leukemia protection from spontaneous in vitro apoptosis, as well as cellular activation with cell cycle progression and cytokine production."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21191401, "text": "soluble CD160, produced by mast cells, may have a role in T-cell-mast cell interactions in vivo"}, {"pubmed": 21276121, "text": "results indicate that CD160+ lymphocytes could be able to play a role in the maintenance of healthy pregnancy"}, {"pubmed": 21482699, "text": "A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor."}, {"pubmed": 21715317, "text": "demonstrated CD160 expression in 98% of chronic lymphocytic leukemia cases, 100% of hairy cell leukemia cases, 15% of mantle cell lymphoma in the leukemic phase, and 16% of other B-cell lymphoproliferative disorders"}, {"pubmed": 21959263, "text": "The results of a mutagenesis study of HVEM suggest that the CD160 binding region on HVEM was slightly different from, but overlapped with, the BTLA binding site."}, {"pubmed": 22172098, "text": "circulating NK cells from PNH patients exhibit a self-MHC class I molecule reactive effector function, which could be mediated through the recruitment of CD160-TM receptor."}, {"pubmed": 22916009, "text": "CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction."}, {"pubmed": 23761635, "text": "CD160-expressing human NK cells are costimulated by HVEM expressed in the environment to enhance cytolytic function and cytokine production."}, {"pubmed": 24882258, "text": "Data suggest that CD160 may become a useful marker in the clinical diagnosis and prognosis of chronic lymphocytic leukemia."}, {"pubmed": 25044837, "text": "A population of CD4+ CD160+ T lymphocytes was identified in circulating cutaneous T cells."}, {"pubmed": 25179432, "text": "Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches."}, {"pubmed": 25277889, "text": "report high frequencies of CD160 on CD8+ T cells, with significantly higher levels on HTLV-1 specific CD8+ T cells"}, {"pubmed": 25449536, "text": "identified 13 ADCC-activated genes. Six gene expression assays including 8 of the 13 genes (CCL3, CCL4/CCL4L1/CCL4L2, CD160, IFNG, NR4A3 and XCL1/XCL2) were analyzed in 127 kidney biopsies"}, {"pubmed": 25470765, "text": "CD160 and CD200 are expressed in B cells in chronic lymphocytic leukemia and are absent in other mature B-cell neoplasms."}, {"pubmed": 25615279, "text": "CD160FCA offers a simple assay for minimal residual disease detection in CLL and gives prognostic information across different CLL risk groups."}, {"pubmed": 26071079, "text": "elevated CD160 expression on natural killer (NK) cells plays an important role in NK cell loss in atherosclerosis."}, {"pubmed": 26269596, "text": "analysis of how NK1 receptor Gs versus Gq proteins and beta-arrestin signaling is determined by interactions in the water hydrogen bond network"}, {"pubmed": 31230945, "text": "Data report the crystal structures of the human CD160 extracellular domain and its complex with human HVEM. CD160 adopts a unique variation of the immunoglobulin fold and exists as a monomer in solution. The CD160:HVEM assembly exhibits a 1:1 stoichiometry and a binding interface similar to that observed in the BTLA:HVEM complex."}, {"pubmed": 32795404, "text": "Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160."}, {"pubmed": 33072082, "text": "CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells."}, {"pubmed": 33931471, "text": "Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia."}, {"pubmed": 34238277, "text": "Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study."}, {"pubmed": 34273660, "text": "CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions."}, {"pubmed": 34709351, "text": "HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160."}, {"pubmed": 35428910, "text": "The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma."}, {"pubmed": 36110864, "text": "CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression."}, {"pubmed": 36163624, "text": "[Expression of CD160 in natural killer (NK) cells from patients with active tuberculosis and its relationship with cell functions]."}, {"pubmed": 37014183, "text": "Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer."}], "genomic_pos": {"chr": "1", "end": 145739288, "ensemblgene": "ENSG00000117281", "start": 145719471, "strand": 1}, "genomic_pos_hg19": [{"chr": "1", "end": 145715614, "start": 145695798, "strand": -1}, {"chr": "HG1287_PATCH", "end": 146425703, "start": 146414640, "strand": 1}], "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002250", "qualifier": "involved_in", "term": "adaptive immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002385", "qualifier": "involved_in", "term": "mucosal immune response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0002729", "pubmed": 17307798, "qualifier": "involved_in", "term": "positive regulation of natural killer cell cytokine production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002857", "qualifier": "involved_in", "term": "positive regulation of natural killer cell mediated immune response to tumor cell"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016525", "pubmed": 16809620, "qualifier": "involved_in", "term": "negative regulation of angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031295", "pubmed": [9973372, 11978774], "qualifier": "involved_in", "term": "T cell costimulation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032729", "qualifier": "involved_in", "term": "positive regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043491", "pubmed": 17307798, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045954", "pubmed": [12486241, 17307798], "qualifier": "involved_in", "term": "positive regulation of natural killer cell mediated cytotoxicity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050829", "qualifier": "involved_in", "term": "defense response to Gram-negative bacterium"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050860", "pubmed": 18193050, "qualifier": "involved_in", "term": "negative regulation of T cell receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1900280", "pubmed": 18193050, "qualifier": "involved_in", "term": "negative regulation of CD4-positive, alpha-beta T cell costimulation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1905675", "pubmed": 18193050, "qualifier": "involved_in", "term": "negative regulation of adaptive immune memory response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000353", "pubmed": 16809620, "qualifier": "involved_in", "term": "positive regulation of endothelial cell apoptotic process"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [9973372, 11978774, 18193050], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098552", "qualifier": "located_in", "term": "side of membrane"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0005102", "pubmed": 9973372, "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11978774, 16809620, 18193050, 25416956, 27152329, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019900", "pubmed": 11978774, "qualifier": "enables", "term": "kinase binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0023024", "qualifier": "enables", "term": "MHC class I protein complex binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0032393", "pubmed": 15494480, "qualifier": "enables", "term": "MHC class I receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0032394", "pubmed": 16809620, "qualifier": "enables", "term": "MHC class Ib receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0032397", "pubmed": [9973372, 11978774, 12486241], "qualifier": "enables", "term": "activating MHC class I receptor activity"}]}, "homologene": {"genes": [[9544, 696832], [9598, 469828], [9606, 11126], [9615, 483158], [10090, 54215], [10116, 502585]], "id": 5122}, "interpro": [{"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}, {"desc": "CD160 ANTIGEN", "id": "IPR042385", "short_desc": "CD160"}], "ipi": ["IPI00443768", "IPI00922521"], "map_location": "1q21.1", "name": "CD160 molecule", "other_names": ["CD160 antigen", "CD160-delta Ig", "natural killer cell receptor BY55", "natural killer cell receptor, immunoglobulin superfamily member"], "pantherdb": {"HGNC": "17013", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1860383", "ortholog_type": "LDO", "panther_family": "PTHR15425", "taxid": 10090, "uniprot_kb": "O88875"}, {"RGD": "1563598", "ortholog_type": "LDO", "panther_family": "PTHR15425", "taxid": 10116, "uniprot_kb": "D3ZBA3"}], "uniprot_kb": "O95971"}, "pathway": {"reactome": [{"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-198933", "name": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"}], "wikipathways": {"id": "WP5039", "name": "SARS-CoV-2 innate immunity evasion and cell-specific immune response"}}, "pdb": ["6NG3", "6NG9", "6NGG", "7MSG"], "pharmgkb": "PA134943137", "pharos": {"target_id": 754, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF262307", "relationship": "is"}, {"id": "GNF262308", "relationship": "is"}, {"id": "GNF262309", "relationship": "is"}, {"id": "GNF262310", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF158385", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF002254", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF109811", "relationship": "is"}, {"id": "GNF149452", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1"], "protein": ["NP_008984.1", "XP_005272986.1", "XP_011507406.1", "XP_054189951.1", "XP_054189952.1"], "rna": ["NM_007053.4", "NR_103845.2", "XM_005272929.4", "XM_011509104.3", "XM_054333976.1", "XM_054333977.1"], "translation": [{"protein": "NP_008984.1", "rna": "NM_007053.4"}, {"protein": "XP_011507406.1", "rna": "XM_011509104.3"}, {"protein": "XP_005272986.1", "rna": "XM_005272929.4"}, {"protein": "XP_054189952.1", "rna": "XM_054333977.1"}, {"protein": "XP_054189951.1", "rna": "XM_054333976.1"}]}, "reporter": {"HG-U133_Plus_2": "207840_at", "HG-U95Av2": "33112_at", "HTA-2_0": "TC01003113.hg.1", "HuEx-1_0": "2432714", "HuGene-1_1": "7919243", "HuGene-2_1": "16692158"}, "retired": 101060629, "summary": "CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules. [provided by RefSeq, Jul 2008].", "symbol": "CD160", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1424685"}, "unigene": ["Hs.740780", "Hs.488237"], "uniprot": {"Swiss-Prot": "O95971", "TrEMBL": "Q6FH89"}, "wikipedia": {"url_stub": "CD160"}}